How Stellest Lenses Help Slow Myopia Progression in Kids

With more screen time, near-focused activities, and less time outdoors, many kids are developing myopia at younger ages - and their prescriptions are progressing faster than ever before. At Harmony Eyecare & Eyewear Gallery, we take a proactive approach to children’s vision through myopia management solutions, including the newly FDA-approved Essilor Stellest lenses.

Understanding Myopia and Why Early Management Matters

 

Myopia occurs when the eye grows too long from front to back, causing distant objects to appear blurry. While glasses can correct blurry vision, they do not address the underlying progression of myopia. As myopia worsens, children face a higher lifetime risk of serious eye health conditions such as retinal detachment, glaucoma, and myopic macular degeneration. The goal of myopia management is not just to help children see clearly today, but to slow the progression of myopia and protect their long-term eye health.

What Are Essilor Stellest Lenses?

 

Essilor Stellest lenses are innovative spectacle lenses specifically designed to slow the progression of myopia in children. Developed by Essilor, these lenses are backed by years of clinical research and have recently received FDA approval, marking a significant milestone in pediatric myopia care.

Unlike traditional single-vision glasses, Stellest lenses are engineered to manage how light focuses on the retina - addressing one of the key drivers of myopia progression rather than simply correcting vision.

How Stellest Lenses Works

 

Essilor Stellest lenses use patented H.A.L.T. (Highly Aspherical Lenslet Target) technology. This advanced design incorporates a constellation of tiny, nearly invisible lenslets across the surface of the lens.

H.A.L.T. technology works by:

•           Creating a specific optical signal that slows abnormal eye growth

•           Maintaining clear central vision while managing peripheral focus

•           Reducing the stimulus that causes myopia to worsen over time

Clinical studies have shown that Stellest lenses can slow myopia progression by an average of 71% when worn as prescribed, making them one of the most effective spectacle-based myopia management options available today.

FDA Approval: What It Means for Families

 

The recent FDA approval of Essilor Stellest lenses is an important reassurance for parents. This approval confirms that the lenses meet rigorous standards for safety and effectiveness in slowing myopia progression in children.

For families, FDA approval means:

•           Confidence in the science behind the lenses

•           Assurance that the treatment has been thoroughly evaluated

•           Access to a clinically proven, non-invasive myopia management option

Stellest Lenses as Part of a Comprehensive Myopia Management Plan

 

At Harmony Eyecare & Eyewear Gallery, we believe myopia management works best when it is personalized. Essilor Stellest lenses can be an excellent standalone solution for many children, or they may be part of a broader myopia management strategy that includes lifestyle guidance and regular monitoring.

Our optometrist, Dr. Julie Mileham, carefully evaluates each child’s vision, eye health, and risk factors to determine whether Stellest lenses are the right choice. Ongoing follow-up visits allow us to track progression and make adjustments as needed.

Find Out If Stellest Lenses Are Right for Your Child

 

Myopia progression in children is a growing concern, but it doesn’t have to be inevitable. With innovative solutions like Essilor Stellest lenses and their advanced H.A.L.T. technology, families can take meaningful steps to slow myopia progression and protect their child’s long-term vision.

If your child has been diagnosed with myopia or you’ve noticed frequent prescription changes, now is the time to act. Contact Harmony Eyecare & Eyewear Gallery to schedule a myopia management consultation and learn more about Stellest lenses. Visit our office Harmony, Pennsylvania, or call (724) 453-4926 to book an appointment today.